Table 2

Type of ICI and clinical outcome at progression

PatientICINo of ICI cyclesSite of progression with ICISystemic treatment after ICI progression
#1Nivo16Me, P, LYes
#2Nivo18L, LiYes
#3Nivo20LYes
#4Nivo28AYes
#5Nivo24L, BYes
#6Nivo42CNSYes
#7Pembro12LYes
#8Nivo32L, CNSNo
  • A, adrenal; B, bone; CL, cervical lymphadenopathies; CNS, central nervous system; ICI, immune checkpoint inhibitor; L, lung; Li, liver; Me, mediastinum; Nivo, nivolumab; P, pleura; Pembro, pembrolizumab.